PREVALENCE OF NON-ALCOHOLIC FATTY LIVER DISEASE AND ADVANCED FIBROSIS IN THE UNITED STATES: A NATIONAL ESTIMATE IN NHANES 2011-2018

This study supports an increased prevalence of NAFLD in specific subpopulations (aged ≥ 65 years, males, Mexican Americans, obese population, and patients with T2D). The observed difference in the prevalence of advanced fibrosis as estimated by NFS and FIB-4 highlights the challenge of choosing optimal cut-off values.